查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球质谱市场 - 2023-2030
市场调查报告书
商品编码
1279709

全球质谱市场 - 2023-2030

Global Mass Spectrometry Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球质谱市场预计将在 2022 年达到 48.301 亿美元，并在 2030 年达到 85.66 亿美元，增长势头强劲。 预计该市场在预测期内（2023-2030 年）的复合年增长率为 7.6%。

质谱法是一种强大的技术，可根据物质的离子电荷比发现、分类和量化物质。 质谱法在这些过程中的有效性使其成为许多生物製药公司和研究实验室进行评估的宝贵工具。 现代质谱技术，如迁移谱和毛细管电泳，用于分离复杂的混合物，如□产品。

质谱法广泛用于食品和饮料、製药和生物研究领域的检测。 新药开发、药物再利用和药物製剂产量的增加正在增加製药行业对安全和质量控製程序的需求。 更严格的政府法规和对质量控制的需求增加使得质谱法在各个行业中得到更频繁的采用。

市场动态

製药行业研发支出的增加推动了质谱市场的增长

质谱在蛋白质组学、基因组学、医院、代谢组学和药物发现中的广泛应用，以及质谱仪小型化、新产品发布和技术突破的增长趋势推动了质谱市场的增长。我来了。

随着科学研究和开发资金的增加，蛋白质组学、药物发现和製药领域对质谱仪的需求预计会增加，从而推动市场增长。 另一个方面是质谱技术的进步使得获得高分辨率和快速测试结果成为可能。 质谱仪用于多种行业，包括药物发现研究、製药和食品安全测试。

不断增加的产品发布和技术进步为製造商创造了有利可图的机会

随着生物技术和製药公司越来越广泛地接受质谱法进行各种研究，它拥有巨大的市场机会。 对质谱分析产品的高需求为製造商提供了有利可图的增长选择。

由于生命科学领域的应用需求，质谱技术得到了发展。 质谱 MALDI-ToF 是一种临床诊断技术，它使用先进的蛋白质模式识别方法，用于诊断疾病。 由于技术发展速度加快，预计市场将在预测期内扩大。

优质产品的定价将阻碍市场增长

中低预算的公司往往买不起这些质谱仪，从而影响了市场。 然而，质谱仪更昂贵，因为它们具有更先进的功能和特性。

除了设备的购买价格外，使系统达到行业标准通常需要大量成本。 由于技术进步和操作效率的提高，对质谱仪的需求随着时间的推移而增加。

但是，随着技术的进步，系统的成本也在提高。 质谱仪的最终用户购买受其价格影响。 质谱市场主要受到这些问题的製约。

COVID-19 影响分析

对于 COVID-19，除了 COVID 之前、COVID 和 COVID 之后的情景外，价格动态（将大流行期间和之后的价格变化与 COVID 之前的情景进行比较）、供需范围（交易限制） ，由于封锁和后续问题导致的供需变化）；

俄乌衝突影响分析

由于该地区的主要市场参与者数量较少，估计俄乌衝突对全球质谱市场的影响较小。 然而，原材料进出口的影响预计在预测期内对全球质谱市场的增长影响不大。

内容

第一章调查方法及范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 按产品类型分类的摘要
  • 片段：按用途
  • 摘要：按地区

第四章市场动态

  • 影响因素
    • 主持人
      • 製药公司的研发费用增加
      • 主要公司的新产品发布和技术进步
    • 约束因素
      • 为昂贵的产品定价
      • 设备成本高
    • 机会
      • 推出新产品并扩大技术进步
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 法律法规分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • COVID-19 期间的情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格和动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 液相色谱仪
  • 气相色谱仪
  • 串联质谱仪
  • 基质辅助激光解吸电离飞行时间质谱仪
  • 离子淌度质谱仪
  • 其他

第 8 章应用

  • 法医毒理学
  • 蛋白质组学研究
  • 诊断
  • 用于临床研究
  • 其他

第9章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第10章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第11章公司简介

  • 安捷伦科技
    • 公司简介
    • 按产品类型分类的产品组合和内容
    • 财务摘要
    • 主要发展状况
  • Bruker Corporation
  • Danaher Corporation
  • Hitachi Ltd
  • JEOL Ltd
  • LECO Corporation
  • MKS Instruments
  • PerkinElmer Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Ltd

第12章 附录

简介目录
Product Code: BT846

Market Overview

The global mass spectrometry market reached US$ 4,830.1 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 8,566.0 million by 2030. The market is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030).

Mass spectrometry is an effective technique for discovering, categorizing, and quantifying substances based on the ion-charge ratio. Given its efficacy in these processes, mass spectrometry has developed into a valuable tool to assess in many biopharmaceutical companies and research organizations. To separate complicated mixtures like derived peptide products, modern mass spectrometry technologies like mobility spectrometry and capillary electrophoresis are used.

In the fields of food and beverages, pharmaceutical, and biological research, mass spectroscopy is widely used for testing. New drug development, drug repurposing, and expanded pharmaceutical formulation production have all enhanced the need for safety and quality control procedures in the pharmaceutical industry. Due to stringent government regulations and growth in the need for quality control, mass spectrometry is being employed more frequently across a variety of industries.

Market Dynamics

Rising R&D Expenditure By The Pharmaceutical Industry Drives The Growth Of The Mass Spectrometry Market.

The increased use of mass spectrometry in proteomics, genomics, hospitals, metabolomics, and pharmaceutical for drug discovery, as well as rising trends in spectrometer miniaturization, new product launches, and technological breakthroughs, are driving the growth of the mass spectrometry market.

As funding for scientific research and development rises, it is projected that demand for mass spectrometers in proteomics, drug discovery, and pharmaceuticals would increase, driving market growth. Because of advancements in mass spectroscopy technology, aspects like speedy test results with great resolution were also able to be raised. Mass spectroscopy is used in many different industries, such as drug research, pharmaceuticals, food safety testing, and others.

Growing Product Launches And Technological Advancements Create Lucrative Opportunities For Manufacturers.

There is a sizable market opportunity for mass spectrometry as it is becoming more widely accepted by biotechnology and pharmaceutical companies for various research studies. Manufacturers are going to have profitable choices for growth as demand for products utilized for mass spectrometry will be high.

As a result of the demands for applications in the life sciences, mass spectrometry technology has evolved. Mass spectrometry MALDI-ToF is a clinical diagnostic technique that uses a highly advanced method of protein pattern recognition to diagnose diseases. Due to the accelerating speed of technological development, it is therefore projected that the market would increase over the projection period.

The Premium Product Pricing Will Hamper The Growth Of The Market.

Because middle- or low-budget businesses frequently cannot afford these mass spectrometer instruments, the market is being impacted. However, because spectrometry equipment has more advanced features and functionalities, it is more expensive.

Additionally to the equipment's purchase price, there are typically significant costs associated with getting the system up to industry standards. Due to advancements in technology and increased operational efficacy, the demand for mass spectrometers has grown over time.

However, as technology has advanced, system costs have increased. The decision of end users to purchase a spectrometer is influenced by its price. The market for mass spectrometry is primarily constrained by these issues.

COVID-19 Impact Analysis

The COVID-19 analysis includes the Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario in addition to pricing dynamics (including pricing change during and after the pandemic evaluating it with pre-COVID scenarios), demand-supply spectrum (shift in demand and supply due to trading restrictions, lockdown, and afterward issues), government initiatives (initiatives to reactivate a market, industry, or sector by government bodies), and manufacturers strategic initiatives.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global mass spectrometry market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global mass spectrometry market growth over the forecast period.

Segment Analysis

The global mass spectrometry market is segmented based on product type, application and region.

Proteomics research from the application segment accounts for 41.7% of the market share owing to rising proteomics studies.

The study of proteins' relationships, biological functions, makeup, and architectures is known as proteomics. In comparison to genomics, proteomics offers a greater grasp of the composition and operation of the organism. However, because the expression of proteins varies with time and environmental factors, it is significantly more complicated than genomics.

Human proteins are thought to number close to a million, and many of them have post-translational modifications (PTMs) and other alterations. One-dimensional (1D) and two-dimensional (2D) gel electrophoresis (2-DE) and gel-free high-throughput screening technologies like label-free measurement of high-mass resolution tandem mass spectrometry and liquid chromatography are just a few of the proteomics techniques available.

Geographical Analysis

North America Accounted For Approximately 38.3% Of The Market Share Owing To The Strong Presence Of Major Players And Increasing Technological Advancements.

Manufacturers have chances to expand their operations in this region because of the rising demand for mass spectrometry for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised the industrial production of mass spectrometry products, which has increased the demand.

Growth is also fueled by rising technological advancements, regulatory approvals, and novel product launches. Individuals are becoming more aware of various kinds of novel studies in various fields such as proteomics, genomics, or drug discovery, leading to the expansion of the market in this region. These factors show the dominance of North America.

Competitive Landscape

The major global players in the mass spectrometry market include: Agilent Technologies, Danaher Corporation, Bruker Corporation, Hitachi Ltd, LECO Corporation, JEOL Ltd, MKS Instruments, Shimadzu Corporation, PerkinElmer Inc. and Thermo Fisher Scientific Ltd among others.

Why Purchase the Report?

  • To visualize the global mass spectrometry market segmentation based on product type, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of mass spectrometry market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global mass spectrometry market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising R&D expenditure by the pharmaceutical industry
      • 4.1.1.2. New product launches and technological advancements by the key players
    • 4.1.2. Restraints
      • 4.1.2.1. The premium product pricing
      • 4.1.2.2. High cost of instruments
    • 4.1.3. Opportunity
      • 4.1.3.1. Growing product launches and technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Liquid Chromatography Spectrometer *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gas chromatography Spectrometer
  • 7.4. Tandem Mass Spectrometer
  • 7.5. Matrix-Assisted Laser Desorption Ionization Time-Of-Flight
  • 7.6. Ion-Mobility Mass Spectrometry
  • 7.7. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Forensic Toxicology *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Proteomics Research
  • 8.4. Diagnostics
  • 8.5. Clinical Research
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. The U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Agilent Technologies *
    • 11.1.1. Company Overview
    • 11.1.2. Product Type Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Bruker Corporation
  • 11.3. Danaher Corporation
  • 11.4. Hitachi Ltd
  • 11.5. JEOL Ltd
  • 11.6. LECO Corporation
  • 11.7. MKS Instruments
  • 11.8. PerkinElmer Inc.
  • 11.9. Shimadzu Corporation
  • 11.10. Thermo Fisher Scientific Ltd

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us